36 related articles for article (PubMed ID: 19631836)
21. TP receptor antagonism: a new concept in atherothrombosis and stroke prevention.
Chamorro A
Cerebrovasc Dis; 2009; 27 Suppl 3():20-7. PubMed ID: 19439937
[TBL] [Abstract][Full Text] [Related]
22. An examination of economic outcomes associated with misdiagnosis or undertreatment of TIA.
Kessler C; Thomas KE
Am J Manag Care; 2009 Jun; 15(6 Suppl):S170-6. PubMed ID: 19601692
[TBL] [Abstract][Full Text] [Related]
23. Hypertension and TIA.
Zhang WW; Cadilhac DA; Donnan GA; O'Callaghan C; Dewey HM
Int J Stroke; 2009 Jun; 4(3):206-14. PubMed ID: 19659823
[TBL] [Abstract][Full Text] [Related]
24. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.
Yakubov S
Curr Med Res Opin; 2009 Nov; 25(11):2631-41. PubMed ID: 19769467
[TBL] [Abstract][Full Text] [Related]
25. Potential survival gains in the treatment of myocardial infarction.
Chew DP; Huynh LT; Liew D; Astley C; Soman A; Brieger D
Heart; 2009 Nov; 95(22):1844-50. PubMed ID: 19666459
[TBL] [Abstract][Full Text] [Related]
26. [Transient ischemic attack, a medical emergency].
Uchiyama S
Brain Nerve; 2009 Sep; 61(9):1013-22. PubMed ID: 19803400
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
Vijan SG
J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
[TBL] [Abstract][Full Text] [Related]
28. Impaired renal function in acute myocardial infarction.
Lekston A; Kurek A; Tynior B
Cardiol J; 2009; 16(5):400-6. PubMed ID: 19753517
[TBL] [Abstract][Full Text] [Related]
29. Patients at high risk of cerebrovascular disease: the REACH study.
Mostaza JM; Martín-Jadraque R; Vicente I; San Martin MA; Lahoz C
Cerebrovasc Dis; 2009; 27 Suppl 1():77-81. PubMed ID: 19342835
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular risk factors in patients at high risk of atherothrombosis: what can be learned from registries?
Goto S
Thromb Haemost; 2008 Oct; 100(4):611-3. PubMed ID: 18841282
[No Abstract] [Full Text] [Related]
31. [Neuro-cardiology or cardio-neurology - a new specialization of the future?].
Widimský P; Štětkářová I
Vnitr Lek; 2015 May; 61(5):484-6. PubMed ID: 26075861
[TBL] [Abstract][Full Text] [Related]
32. [Implications of the REACH registry for neurologists].
Roquer J
Med Clin (Barc); 2009 Sep; 132 Suppl 2():30-3. PubMed ID: 19631836
[TBL] [Abstract][Full Text] [Related]
33. Baseline characteristics of patients with cerebrovascular disease in the REACH registry: the Spanish contribution.
Suárez C;
Cerebrovasc Dis; 2007; 24 Suppl 1():89-95. PubMed ID: 17971643
[TBL] [Abstract][Full Text] [Related]
34. The burden of peripheral artery disease and the role of antiplatelet therapy.
Aronow H; Hiatt WR
Postgrad Med; 2009 Jul; 121(4):123-35. PubMed ID: 19641278
[TBL] [Abstract][Full Text] [Related]
35. Thrombosis prophylaxis in patients with ischaemic (cardioembolic) stroke. How long is long enough?
Lip GY; Krishnamoorthy S
Hamostaseologie; 2009 Jan; 29(1):96-101. PubMed ID: 19151857
[TBL] [Abstract][Full Text] [Related]
36. Predicting and preventing stroke after transient ischemic attack.
de Lau LM; den Hertog HM; van den Herik EG; Koudstaal PJ
Expert Rev Neurother; 2009 Aug; 9(8):1159-70. PubMed ID: 19673605
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
